How many drugs treat Social phobia?

Drug Landscape tracks 5 marketed treatments for Social phobia (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/social-phobia.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Social phobia — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Social phobia (disease) competitive landscape: 5 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

5 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Social phobia, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Effexor	venlafaxine	Generic (originally Wyeth/Pfizer)	SNRI (Serotonin-norepinephrine reuptake inhibitor)	5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C	1993-12-28
Effexor	Venlafaxine Hydrochloride	Pfizer	Serotonin-Norepinephrine Reuptake Inhibitor (SNRI)	Serotonin and norepinephrine reuptake transporters	1993-01-01
Zoloft	sertraline	Pfizer Inc.	SSRI (Selective serotonin reuptake inhibitor)	Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A	1991-12-30
Sertralin	Sertralin	Poznan University of Medical Sciences		Cytochrome P450 2C19, Melanocortin receptor 5, 5-hydroxytryptamine receptor 2A
Effexor	Effexor	Wyeth is now a wholly owned subsidiary of Pfizer		5-hydroxytryptamine receptor 6, 5-hydroxytryptamine receptor 2A, 5-hydroxytryptamine receptor 2C

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

· 1 drug in Social phobia
Generic (originally Wyeth/Pfizer) · 1 drug in Social phobia
Pfizer · 1 drug in Social phobia
Pfizer Inc. · 1 drug in Social phobia
Poznan University of Medical Sciences · 1 drug in Social phobia
Wyeth is now a wholly owned subsidiary of Pfizer · 1 drug in Social phobia

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Social phobia:

Cite this brief

Drug Landscape (2026). Social phobia — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/social-phobia. Accessed 2026-06-10.

Social phobia full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing